Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastases. Read more about Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastases.
Herpes simplex encephalitis in a patient with recurrent pituitary adenoma receiving radiation therapy. Read more about Herpes simplex encephalitis in a patient with recurrent pituitary adenoma receiving radiation therapy.
Preliminary investigation of symptom distress in the head and neck patient population: validation of a measurement instrument. Read more about Preliminary investigation of symptom distress in the head and neck patient population: validation of a measurement instrument.
Influence of number of CAG repeats on local control in the RTOG 86-10 protocol. Read more about Influence of number of CAG repeats on local control in the RTOG 86-10 protocol.
Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Read more about Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx.
High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancer. Read more about High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancer.
Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results. Read more about Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results.
Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial. Read more about Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial.
Evaluation of 45 degrees C hyperthermia and irradiation. II. A phase I clinical trial in humans by the Radiation Therapy Oncology Group. Read more about Evaluation of 45 degrees C hyperthermia and irradiation. II. A phase I clinical trial in humans by the Radiation Therapy Oncology Group.
